Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

Article Properties

Language

English
DOI (url)

10.1007/s00228-008-0553-z
Publication Date

2008/09/02
Journal

European Journal of Clinical Pharmacology
Indian UGC (Journal)
Refrences

142
Citations

416
Roger K. Verbeeck

Cite

Verbeeck, Roger K. “Pharmacokinetics and Dosage Adjustment in Patients With Hepatic Dysfunction”. European Journal of Clinical Pharmacology, vol. 64, no. 12, 2008, pp. 1147-61, https://doi.org/10.1007/s00228-008-0553-z.

Verbeeck, R. K. (2008). Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. European Journal of Clinical Pharmacology, 64(12), 1147-1161. https://doi.org/10.1007/s00228-008-0553-z

Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. European Journal of Clinical Pharmacology. 2008;64(12):1147-61.

Journal Categories

Medicine

Public aspects of medicine

Toxicology

Poisons

Medicine

Therapeutics

Pharmacology

Refrences

Refrences Analysis

Category	Category Repetition
Medicine: Public aspects of medicine: Toxicology. Poisons	101
Medicine: Therapeutics. Pharmacology	56
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology	26
Medicine: Medicine (General)	26
Medicine	13

The category Medicine: Public aspects of medicine: Toxicology. Poisons 101 is the most frequently represented among the references in this article. It primarily includes studies from Clinical Pharmacokinetics The chart below illustrates the number of referenced publications per year.

Refrences used by this article by year

Citations

Citations Analysis

Category	Category Repetition
Medicine: Therapeutics. Pharmacology	230
Medicine: Public aspects of medicine: Toxicology. Poisons	218
Medicine: Medicine (General)	101
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology	41
Science: Biology (General)	25

The first research to cite this article was titled Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment and was published in 2008. The most recent citation comes from a 2024 study titled Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment . This article reached its peak citation in 2023 , with 38 citations.It has been cited in 225 different journals, 20% of which are open access. Among related journals, the Clinical Pharmacokinetics cited this research the most, with 22 citations. The chart below illustrates the annual citation trends for this article.